ARQ 092

ARQ-092 · ArQule, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARQ 092, covering 2017-10-23 to 2017-10-23. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma [Phase 1]

See pricing